Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A 3D InSight into drug discovery with Tecanís Infinite M200 PRO
August 2013
SHARING OPTIONS:

Tecan  

A novel solution for analyzing 3D cell cultures, based on Tecan's Infinite M200 PRO and InSphero's 3D InSight microtissue technology, is helping to reduce the cost of early-phase drug development. Dr. Jens M. Kelm, co-founder and chief scientific officer of InSphero, explains: "Although classical 2D cell culture techniques are still widely used throughout the pharmaceutical industry, their limitations are becoming increasingly apparent. The efficacy of a candidate drug depends on a number of factors, including the physical and chemical environments in vivo, drug penetration and clearance rates. 2D cell cultures do not accurately reflect how all of these factors will affect drug behavior in vivo; 3D cell culturing techniques offer greater biological relevance for drug screening."
 

Tecan

www.tecan.com
  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.